title: New pharmacoeconomic option in uremic anemia management.
authors: V
authors: V
authors: Savica
authors: L
authors: L
authors: Mantovani
authors: D
authors: D
authors: Santoro
authors: B
authors: B
authors: Ricciardi
authors: G
authors: G
authors: Bellinghieri
mesh_terms: D000368:Aged; D000740:Anemia / Q000188:drug therapy* / Q000191:economics / Q000209:etiology; D003362:Cost-Benefit Analysis; D000068256:Darbepoetin alfa; D016527:Drug Costs; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use; D005260:Female; D006397:Hematinics / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011994:Recombinant Proteins; D014511:Uremia / Q000150:complications*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa